ARDT - CIK 0001756655
The table below shows Ardent Health, Inc.'s cash flow statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating cash flow | $470.51M | $315.03M | $221.70M | -$38.36M |
| Capital expenditure | - | - | - | - |
| Investing cash flow | -$214.23M | -$220.46M | -$137.98M | $46.58M |
| Dividends paid | - | $0.00 | $0.00 | $174.81M |
| Stock buybacks | - | - | - | - |
| Financing cash flow | -$103.47M | $24.64M | -$102.26M |
Ardent Health, Inc. reported operating cash flow of $470.51M for fiscal year 2025. That is up 49.4% from $315.03M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$270.33M |